Sponsor pipeline

Pierre Fabre Medicament clinical trial pipeline

Get alerts when Pierre Fabre Medicament's trials change

9 active trials 5 recruiting 2 Phase 3 5 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
3
Phase 2
2
Phase 3
2
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT03394365 A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated… Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) Recruiting 2026-09-02
NCT05270044 Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. Melanoma Active, Not Recruiting 2023-11-22
Phase 2
NCT04554914 A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV)… Epstein-Barr Virus (EBV)-Associated Diseases Active, Not Recruiting 2026-07-31
NCT05195632 Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E… Non-Small Cell Lung Cancer Active, Not Recruiting 2026-05-01
Phase 1/2
NCT06043817 First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or… Non-Small Cell Lung Cancer Recruiting 2026-09-02
NCT06567015 Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs Non-small Cell Lung Cancer (NSCLC) Recruiting 2026-09-02
NCT06669117 FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With… Solid Tumor Recruiting 2025-07-02
Phase 1
NCT04913285 A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive… Solid Tumor, Adult Recruiting 2026-09-02
Not specified
NCT06500494 To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer… Advanced Breast Cancer Active, Not Recruiting 2026-07-02

Disease areas by active trials

Lung Cancer (4) · Non-Small Cell Lung Cancer (NSCLC) (4) · Melanoma (2) · Breast Cancer (1) · Sarcoma (1)

Get alerts when Pierre Fabre Medicament's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free